| Item Type | Name |
|
Concept
|
Acute Disease
|
|
Concept
|
Antigens, Neoplasm
|
|
Concept
|
Birds
|
|
Concept
|
Antigens, Differentiation
|
|
Concept
|
Antigens, Surface
|
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Aneuploidy
|
|
Concept
|
Animals
|
|
Concept
|
Antimetabolites, Antineoplastic
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Bufonidae
|
|
Concept
|
Carcinoma, Bronchogenic
|
|
Concept
|
Chromosome Banding
|
|
Concept
|
Chromosomes, Human, Pair 11
|
|
Concept
|
Chromosomes, Human, Pair 2
|
|
Concept
|
Chromosomes, Human, Pair 6
|
|
Concept
|
Antitubercular Agents
|
|
Concept
|
Analysis of Variance
|
|
Concept
|
Animals, Zoo
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
Antigens, Differentiation, T-Lymphocyte
|
|
Concept
|
Chromosomes, Human, Pair 8
|
|
Concept
|
Cyclosporins
|
|
Concept
|
Cytoplasmic Granules
|
|
Concept
|
Antigens, Differentiation, B-Lymphocyte
|
|
Concept
|
B-Lymphocytes
|
|
Concept
|
Base Sequence
|
|
Concept
|
Benzamides
|
|
Concept
|
Cell Count
|
|
Concept
|
Azacitidine
|
|
Concept
|
Binding Sites
|
|
Concept
|
Blast Crisis
|
|
Concept
|
Biopsy, Needle
|
|
Concept
|
Biopsy
|
|
Concept
|
Cell Division
|
|
Concept
|
Chromosomes, Human, Pair 21
|
|
Concept
|
Chromosomes, Human, Pair 3
|
|
Concept
|
Chromosomes, Human, 4-5
|
|
Concept
|
Chromosomes, Human, Pair 12
|
|
Concept
|
Chromosomes, Human, Pair 14
|
|
Concept
|
Chromosomes, Human, 6-12 and X
|
|
Concept
|
Cell Transformation, Neoplastic
|
|
Concept
|
Uterine Cervical Neoplasms
|
|
Concept
|
Chromosome Deletion
|
|
Concept
|
Chromosomes, Human, Pair 13
|
|
Concept
|
Chromosomes, Human, Pair 22
|
|
Concept
|
Burkitt Lymphoma
|
|
Concept
|
Genes, Immunoglobulin
|
|
Concept
|
Chromosomes, Human, Pair 5
|
|
Concept
|
Chromosomes, Human, Pair 7
|
|
Concept
|
Chromosomes, Human, 13-15
|
|
Concept
|
Chromosomes, Human, 16-18
|
|
Concept
|
Chromosomes, Human, 21-22 and Y
|
|
Concept
|
Colony-Stimulating Factors
|
|
Concept
|
DNA-Binding Proteins
|
|
Concept
|
Interleukin-2
|
|
Concept
|
Leukemia, Erythroblastic, Acute
|
|
Concept
|
Down Syndrome
|
|
Concept
|
DNA Mutational Analysis
|
|
Concept
|
DNA, Neoplasm
|
|
Concept
|
Cyclophosphamide
|
|
Concept
|
Daunorubicin
|
|
Concept
|
Europe
|
|
Concept
|
Glucocorticoids
|
|
Concept
|
Enzyme Inhibitors
|
|
Concept
|
Leukemia
|
|
Concept
|
Leukemia, Lymphoid
|
|
Concept
|
Leukemia, Megakaryoblastic, Acute
|
|
Concept
|
Immunologic Factors
|
|
Concept
|
Chromosomes, Human, Pair 17
|
|
Concept
|
Chromosomes, Human, Pair 9
|
|
Concept
|
Chromosomes, Human, 19-20
|
|
Concept
|
Chronic Disease
|
|
Concept
|
Erythropoietin
|
|
Concept
|
Etoposide
|
|
Concept
|
Cross-Sectional Studies
|
|
Concept
|
Cytarabine
|
|
Concept
|
DNA
|
|
Concept
|
Double-Blind Method
|
|
Concept
|
Interferons
|
|
Concept
|
Chromosome Inversion
|
|
Concept
|
Methyltransferases
|
|
Concept
|
Terminology as Topic
|
|
Concept
|
Karyotyping
|
|
Concept
|
DNA (Cytosine-5-)-Methyltransferases
|
|
Concept
|
Histocytochemistry
|
|
Concept
|
DNA, Viral
|
|
Concept
|
Dose-Response Relationship, Drug
|
|
Concept
|
Immune Sera
|
|
Concept
|
Lions
|
|
Concept
|
Eosinophilia
|
|
Concept
|
Histocompatibility Testing
|
|
Concept
|
Hypergammaglobulinemia
|
|
Concept
|
Flow Cytometry
|
|
Concept
|
Immunity, Cellular
|
|
Concept
|
Immunoglobulin gamma-Chains
|
|
Concept
|
Infusions, Intravenous
|
|
Concept
|
Macrophages
|
|
Concept
|
Hepatitis C
|
|
Concept
|
Lymphocyte Culture Test, Mixed
|
|
Concept
|
Pilot Projects
|
|
Concept
|
Lymphopenia
|
|
Concept
|
Mice, Inbred CBA
|
|
Concept
|
Neutropenia
|
|
Concept
|
Mastocytosis
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Mutagens
|
|
Concept
|
Neoplastic Cells, Circulating
|
|
Concept
|
Methotrexate
|
|
Concept
|
Mice, Inbred C57BL
|
|
Concept
|
Random Allocation
|
|
Concept
|
Mitoxantrone
|
|
Concept
|
Pathology, Clinical
|
|
Concept
|
Periodic Acid-Schiff Reaction
|
|
Concept
|
Interleukin-3
|
|
Concept
|
Neutrophils
|
|
Concept
|
Neck
|
|
Concept
|
Phagocytosis
|
|
Concept
|
Philadelphia Chromosome
|
|
Concept
|
Lung Neoplasms
|
|
Concept
|
Lymphokines
|
|
Concept
|
Microscopy, Electron
|
|
Concept
|
Fibrosis
|
|
Concept
|
Polycythemia Vera
|
|
Concept
|
Prednisone
|
|
Concept
|
Plasma Cells
|
|
Concept
|
Hodgkin Disease
|
|
Concept
|
Immunoglobulin G
|
|
Concept
|
Immunoenzyme Techniques
|
|
Concept
|
Radiation Injuries
|
|
Concept
|
Recurrence
|
|
Concept
|
Remission, Spontaneous
|
|
Concept
|
Haemophilus
|
|
Concept
|
RNA-Directed DNA Polymerase
|
|
Concept
|
Risk Factors
|
|
Concept
|
Rosette Formation
|
|
Concept
|
Receptors, Antigen, B-Cell
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor
|
|
Concept
|
Polymorphism, Restriction Fragment Length
|
|
Concept
|
Leukemia, B-Cell
|
|
Concept
|
Snakes
|
|
Concept
|
Risk
|
|
Concept
|
Sensitivity and Specificity
|
|
Concept
|
Thymidine
|
|
Concept
|
Hepatitis, Viral, Human
|
|
Concept
|
Sigmoid Neoplasms
|
|
Concept
|
Humans
|
|
Concept
|
Leukemia, Mast-Cell
|
|
Concept
|
Leukemia, Radiation-Induced
|
|
Concept
|
Leukocyte Count
|
|
Concept
|
Leukopenia
|
|
Concept
|
Incidence
|
|
Concept
|
Cluster Analysis
|
|
Concept
|
Bone Marrow Transplantation
|
|
Concept
|
Thalidomide
|
|
Concept
|
Immunoglobulin lambda-Chains
|
|
Concept
|
Interferon Type I
|
|
Concept
|
United States
|
|
Concept
|
Syndrome
|
|
Concept
|
Trisomy
|
|
Concept
|
Clinical Trials, Phase I as Topic
|
|
Concept
|
Ki-1 Antigen
|
|
Concept
|
Germ-Line Mutation
|
|
Concept
|
Leukemia, Lymphocytic, Chronic, B-Cell
|
|
Concept
|
Leukemia, Myeloid, Accelerated Phase
|
|
Concept
|
Leukemia, Myeloid
|
|
Concept
|
Lymphocytosis
|
|
Concept
|
Lymphoid Tissue
|
|
Concept
|
Lymphoma, Follicular
|
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
|
Concept
|
Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor
|
|
Concept
|
Oncogene Proteins, Fusion
|
|
Concept
|
Proportional Hazards Models
|
|
Concept
|
CD11 Antigens
|
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
|
Concept
|
Gene Duplication
|
|
Concept
|
Vidarabine
|
|
Concept
|
Receptors, Colony-Stimulating Factor
|
|
Concept
|
Central Nervous System Neoplasms
|
|
Concept
|
Mice, Inbred DBA
|
|
Concept
|
Receptors, Interleukin-2
|
|
Concept
|
Pentostatin
|
|
Concept
|
Antigens, CD
|
|
Concept
|
Lymph Nodes
|
|
Concept
|
Lymphoma
|
|
Concept
|
Multiple Myeloma
|
|
Concept
|
DNA Probes
|
|
Concept
|
Leukemia, Myeloid, Acute
|
|
Concept
|
Clinical Trials, Phase II as Topic
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Sequence Analysis, DNA
|
|
Concept
|
Methylation
|
|
Concept
|
Receptors, Antigen, T-Cell, alpha-beta
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Mycobacterium Infections, Nontuberculous
|
|
Concept
|
Neoplasm Metastasis
|
|
Concept
|
Neoplasm Recurrence, Local
|
|
Concept
|
Genomic Instability
|
|
Concept
|
Interferon-alpha
|
|
Concept
|
Gene Deletion
|
|
Concept
|
Sequence Deletion
|
|
Concept
|
Mice, Knockout
|
|
Concept
|
Receptors, Interferon
|
|
Concept
|
Antigens, CD34
|
|
Concept
|
Disease Progression
|
|
Concept
|
Antineoplastic Agents, Alkylating
|
|
Concept
|
Antigens, CD20
|
|
Concept
|
Angiogenesis Inhibitors
|
|
Concept
|
Receptor Protein-Tyrosine Kinases
|
|
Concept
|
Osteolysis
|
|
Concept
|
Bone Marrow Neoplasms
|
|
Concept
|
Cladribine
|
|
Concept
|
In Situ Hybridization, Fluorescence
|
|
Concept
|
Carcinoma, Small Cell
|
|
Concept
|
Proto-Oncogene Proteins c-kit
|
|
Concept
|
Receptor, Platelet-Derived Growth Factor alpha
|
|
Concept
|
Platelet Count
|
|
Concept
|
Mice
|
|
Concept
|
Quinacrine Mustard
|
|
Concept
|
Severity of Illness Index
|
|
Concept
|
RNA, Messenger
|
|
Concept
|
Mastocytosis, Systemic
|
|
Concept
|
GATA1 Transcription Factor
|
|
Concept
|
Kruppel-Like Transcription Factors
|
|
Concept
|
Real-Time Polymerase Chain Reaction
|
|
Concept
|
Skin Neoplasms
|
|
Concept
|
Spleen
|
|
Concept
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
|
Concept
|
Tartrates
|
|
Concept
|
Life Tables
|
|
Concept
|
Multivariate Analysis
|
|
Concept
|
Logistic Models
|
|
Concept
|
Survival Analysis
|
|
Concept
|
Lymphoma, B-Cell
|
|
Concept
|
CD4-CD8 Ratio
|
|
Concept
|
Abnormal Karyotype
|
|
Concept
|
Gene Expression Regulation, Leukemic
|
|
Concept
|
Survival Rate
|
|
Concept
|
Confidence Intervals
|
|
Concept
|
Fusion Proteins, bcr-abl
|
|
Concept
|
Lymphocyte Subsets
|
|
Concept
|
Polymerase Chain Reaction
|
|
Concept
|
Granulocyte Colony-Stimulating Factor
|
|
Concept
|
Patient Selection
|
|
Concept
|
CD2 Antigens
|
|
Concept
|
Lymphoma, Large B-Cell, Diffuse
|
|
Concept
|
Leukemic Infiltration
|
|
Concept
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
|
Concept
|
Statistics, Nonparametric
|
|
Concept
|
Cell Lineage
|
|
Concept
|
Hematologic Neoplasms
|
|
Concept
|
Tandem Repeat Sequences
|
|
Concept
|
Heterogeneous-Nuclear Ribonucleoprotein K
|
|
Concept
|
Mitogen-Activated Protein Kinase 9
|
|
Concept
|
T-Lymphocytes, Regulatory
|
|
Concept
|
RNA, Small Interfering
|
|
Concept
|
Antibodies, Monoclonal, Murine-Derived
|
|
Concept
|
Tissue Array Analysis
|
|
Concept
|
Myeloid-Lymphoid Leukemia Protein
|
|
Concept
|
fms-Like Tyrosine Kinase 3
|
|
Concept
|
Composite Lymphoma
|
|
Concept
|
Topoisomerase II Inhibitors
|
|
Concept
|
Blood Cell Count
|
|
Concept
|
Chlorambucil
|
|
Concept
|
Chromosome Aberrations
|
|
Concept
|
Chromosomes, Human, Pair 16
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Cytosine
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
Fluorescent Dyes
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Hedgehogs
|
|
Concept
|
Hematinics
|
|
Concept
|
Hemoglobinuria, Paroxysmal
|
|
Concept
|
Histiocytes
|
|
Concept
|
Immunoglobulin kappa-Chains
|
|
Concept
|
Leukemia, Hairy Cell
|
|
Concept
|
Leukemia, Monocytic, Acute
|
|
Concept
|
Lymphocytes
|
|
Concept
|
Lymphoma, Non-Hodgkin
|
|
Concept
|
Metals
|
|
Concept
|
Monocytes
|
|
Concept
|
Monosomy
|
|
Concept
|
Mycobacterium Infections
|
|
Concept
|
Nontuberculous Mycobacteria
|
|
Concept
|
Predictive Value of Tests
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Receptors, Antigen, T-Cell
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Mast-Cell Sarcoma
|
|
Concept
|
Sclerosis
|
|
Concept
|
Splenic Neoplasms
|
|
Concept
|
Staining and Labeling
|
|
Concept
|
T-Lymphocytes
|
|
Concept
|
Translocation, Genetic
|
|
Concept
|
World Health Organization
|
|
Concept
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
|
|
Concept
|
Immunophenotyping
|
|
Concept
|
Granulocyte-Macrophage Colony-Stimulating Factor
|
|
Concept
|
Lymphoma, T-Cell, Peripheral
|
|
Concept
|
DNA Primers
|
|
Concept
|
Disease-Free Survival
|
|
Concept
|
CD5 Antigens
|
|
Concept
|
fas Receptor
|
|
Concept
|
Point-of-Care Systems
|
|
Concept
|
Genetic Predisposition to Disease
|
|
Concept
|
Polymorphism, Single Nucleotide
|
|
Concept
|
Cytogenetic Analysis
|
|
Concept
|
Receptor, Platelet-Derived Growth Factor beta
|
|
Concept
|
MicroRNAs
|
|
Concept
|
Cyclin-Dependent Kinase 9
|
|
Academic Article
|
Acute myeloid leukaemia following interferon-alfa treatment of hairy cell leukaemia.
|
|
Academic Article
|
Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes.
|
|
Academic Article
|
Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model.
|
|
Academic Article
|
Expression of the IFN alpha receptor in hairy cell leukaemia.
|
|
Academic Article
|
Issues in the pathology of the myelodysplastic syndromes.
|
|
Academic Article
|
The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997.
|
|
Academic Article
|
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.
|
|
Academic Article
|
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.
|
|
Academic Article
|
Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia.
|
|
Academic Article
|
Hypergranular promyelocytic leukemia (APL): cytogenetic and ultrastructural specificity.
|
|
Academic Article
|
Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11).
|
|
Academic Article
|
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study.
|
|
Academic Article
|
Detection of numerical chromosomal abnormalities in neoplastic hematopoietic cells by in situ hybridization with a chromosome-specific probe.
|
|
Academic Article
|
Nonlymphoblastic T-cell lymphoma in children.
|
|
Academic Article
|
Acute nonlymphocytic leukemia in adults: correlations with Q-banded chromosomes.
|
|
Academic Article
|
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT).
|
|
Academic Article
|
Human T-cell lymphoma with suppressor effects on the mixed lymphocyte reaction (MLR). I. Morphological and cytogenetic analysis.
|
|
Academic Article
|
Morphologic and cytochemical observations on the overt leukemic phase of therapy-related leukemia.
|
|
Academic Article
|
Surface immunoglobulin, lectin-induced cap formation, and phagocytic function in five patients with the leukemic phase of hairy cell leukemia.
|
|
Academic Article
|
Surface immunoglobulins on hairy cells of 55 patients with hairy cell leukemia.
|
|
Academic Article
|
Complex rearrangement of the T cell receptor in large granular lymphocytosis associated with myeloid suppression.
|
|
Academic Article
|
Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement.
|
|
Academic Article
|
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.
|
|
Academic Article
|
Ultrastructural characterization of de novo and secondary leukemias.
|
|
Academic Article
|
Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease.
|
|
Academic Article
|
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.
|
|
Academic Article
|
miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia.
|
|
Academic Article
|
A recurring chromosome rearrangement, dic(16;22), in acute nonlymphocytic leukemia.
|
|
Academic Article
|
Neutrophilic leucocyte alkaline phosphatase scores in hairy cell leukaemia: cytochemical, functional, and clinical correlations.
|
|
Academic Article
|
Chlorambucil therapy of twenty-four postsplenectomy patients with progressive hairy cell leukemia.
|
|
Academic Article
|
Dysmyelopoietic syndrome: sequential clinical and cytogenetic studies.
|
|
Academic Article
|
Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21).
|
|
Academic Article
|
Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study.
|
|
Academic Article
|
Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.
|
|
Academic Article
|
A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes.
|
|
Academic Article
|
Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461.
|
|
Academic Article
|
Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up.
|
|
Academic Article
|
"Microgranular" acute promyelocytic leukemia: a distinct clinical, ultrastructural, and cytogenetic entity.
|
|
Academic Article
|
HTLV-I sequence in lymphoproliferative disorders.
|
|
Academic Article
|
Familial Lymphoproliferative Disorders with Chromosomal Fragile Site Analysis.
|
|
Academic Article
|
RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia.
|
|
Academic Article
|
Author Correction: RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia.
|
|
Concept
|
Imatinib Mesylate
|
|
Concept
|
Rituximab
|
|
Concept
|
RUNX1 Translocation Partner 1 Protein
|
|
Concept
|
Promyelocytic Leukemia Zinc Finger Protein
|
|
Concept
|
Patient Outcome Assessment
|